Justification Memorandum for 83-I change request

0785 Justification Memo for 83-I change request.docx

Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements

Justification Memorandum for 83-I change request

OMB: 0910-0785

Document [docx]
Download: docx | pdf

Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements”

(OMB Control Number 0910-0785)



Change Request (83-C)

October 13, 2015



The Food and Drug Administration is submitting this nonmaterial/non-substantive change request (83-C) for changes to the pretest and main study questionnaire. These changes include revisions to instructions and questions, and result from cognitive interview findings. There is no change to the burden or data elements.


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorBetts, Kevin
File Modified0000-00-00
File Created2021-01-24

© 2024 OMB.report | Privacy Policy